Butterfly Medical Advances Minimally Invasive BPH Technology With $21M
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
RAMAT-GAN, Israel, May 14, 2026 Galmed Pharmaceuticals Ltd. announced positive results from its first-in-human pharmacokinetics study evaluating the oral...
NEW YORK, May 15, 2026 Protara Therapeutics, Inc. announced positive updated 12-month data from the fully enrolled BCG-Naïve cohort...
LATHAM, N.Y., May 13, 2026 AngioDynamics announced new two-year data from the pivotal PRESERVE clinical trial, demonstrating that its...
RAHWAY, N.J. — December 3, 2025 — Mexico’s Secretariat of Agriculture and Rural Development (SADER) has granted approval for...
Minneapolis, MN — December 3, 2025 — Medtronic announced that the U.S. Food and Drug Administration (FDA) has granted...
ANTWERP, Belgium – November 12, 2025 — Minze Health, a digital health company focused on urinary and bladder conditions,...
